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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYSubstrate composition significantly impacts human pluripotent stem cell (hPSC) self-renewal and differentiation, but relatively little is
known about the role of endogenously produced extracellular matrix (ECM) components in regulating hPSC fates. Here we identify a-5
laminin as a signature ECM component endogenously synthesized by undifferentiated hPSCs cultured on defined substrates. Inducible
shRNA knockdown and Cas9-mediated disruption of the LAMA5 gene dramatically reduced hPSC self-renewal and increased apoptosis
without affecting the expression of pluripotencymarkers. Increased self-renewal and survivalwas restored towild-type levels by culturing
the LAMA5-deficient cells on exogenous laminin-521. Furthermore, treatment of LAMA5-deficient cells with blebbistatin or a ROCK in-
hibitor partially restored self-renewal and diminished apoptosis. These results demonstrate that endogenous a-5 laminin promotes hPSC
self-renewal in an autocrine and paracrinemanner. This finding has implications for understanding how stem cells dynamically regulate
their microenvironment to promote self-renewal and provides guidance for efforts to design substrates for stem cell bioprocessing.INTRODUCTION
The extracellularmatrix (ECM) is known to play an integral
role in human pluripotent stem cell (hPSC) culture and
maintenance. In the absence of appropriate substrate
cues, hPSCs spontaneously differentiate, which has led to
the development of numerous culture approaches and sub-
strates intended tomaintain pluripotency in hPSC cultures
(Domogatskaya et al., 2008; Evseenko et al., 2009). Efforts
in recent years (Chen et al., 2011; Mei et al., 2010; Melkou-
mian et al., 2010; Rodin et al., 2014b; Saha et al., 2011;
Villa-Diaz et al., 2013) have specifically focused on the
development of fully defined, xeno-free culture substrates
as alternatives to the use of mouse embryonic fibroblast
(MEF) feeder cells (Thomson et al., 1998) or Matrigel (Lud-
wig et al., 2006). Use of a defined, xeno-free culture envi-
ronment is important for the performance of controlled
in vitro investigations and for the clinical or commercial
application of hPSCs (Azarin and Palecek, 2010; Chen
et al., 2011).
Both natural and synthetic approaches have been used
to generate fully defined hPSC culture substrates. ECM pro-
teins such as vitronectin and laminins 511 and 521 have
been shown to maintain hESC pluripotency and self-
renewal (Braam et al., 2008; Domogatskaya et al., 2012;
Miyazaki et al., 2012; Rodin et al., 2010, 2014a, 2014b;
Yurchenco, 2011). However, not all ECM proteins are suit-
able for hPSC maintenance because collagens and fibro-
nectin are not able to support an undifferentiated hPSCStem Cpopulation (Azarin and Palecek, 2010; Braam et al., 2008;
Evseenko et al., 2009; Miyazaki et al., 2012; Rodin et al.,
2010; Villa-Diaz et al., 2013). Other fully defined hPSC cul-
ture environments have been produced by modification of
substrates with recombinant E-cadherin (marketed as Ste-
mAdhere) (Nagaoka et al., 2010) or engineeredpeptide coat-
ings (marketed as Synthemax) (Melkoumian et al., 2010).
Although many studies have applied exogenous ECM
components to create hPSC culture substrates, relatively lit-
tle attention has been given to the role of the endogenously
produced ECM in hPSC self-renewal. Specifically, it is un-
known whether there exists a common ECM ‘‘signature’’
produced by hPSCs cultured on substrates known to sup-
port the maintenance of undifferentiated hPSC culture.
The identification of such an ECM signature—i.e., specific
ECM components that are commonly produced across
undifferentiated hPSCs maintained in different culture en-
vironments—could lead to a better understanding of how
hPSCs regulate self-renewal.
In this study, we first identified a-5 laminin as a predom-
inant ECM component produced endogenously by undif-
ferentiated hPSCs—both human embryonic stem cells
(hESCs) and induced pluripotent stem cells (iPSCs)—
cultured on various defined substrates and then employed
two different genetic manipulation strategies to disrupt a-5
laminin production to investigate the role of a-5 laminin in
hPSC self-renewal and pluripotency. Our findings impli-
cate a-5 laminin as a critical autocrine and paracrine factor
that regulates hPSC survival and self-renewal.ell Reports j Vol. 5 j 195–206 j August 11, 2015 j ª2015 The Authors 195
Figure 1. Immunofluorescent Staining
of ECM Proteins Deposited by hPSCs
Cultured under Fully Defined Conditions
H9 hESCs and 19-9-11 iPSCs were cultured
on Synthemax for 5 days in E8 medium and
stained for the indicated ECM proteins.
Production of laminin (and, in particular,
a-5 laminin) was the only common ECM
feature across all substrates and both cell
lines. Scale bars, 100 mm. See also Figures
S1 and S6. VN, vitronectin; Col I, collagen
type I; FN, fibronectin.RESULTS
a-5 Laminin Is Produced by hPSCs under Defined
Culture Conditions
The ECM deposition profile of undifferentiated hPSCs
cultured under defined conditions was evaluated by
culturing H9 hESCs and 19-9-11 iPSCs on Synthemax,
E-cadherin (StemAdhere), or recombinant human vitro-
nectin in E8 medium for 5 days, followed by immunofluo-
rescence detection of laminin, collagen I, fibronectin, and
vitronectin (Figure 1; Figures S1A and S1B). Of these ECM
proteins, only the production of laminin and, specifically,
a-5 laminin was common across all substrates and both
hPSC lines (Figure 1).
Generation and Characterization of Inducible shRNA
and Cas9 a-5 Laminin Knockout Lines
Two different genetic manipulation strategies were imple-
mented to investigate the role of a-5 laminin in hPSC
maintenance. In one approach, H9 and 19-9-11 cell lines
were transduced with an inducible short hairpin RNA
(shRNA) sequence (Table S1) targeting a-5 laminin (ish-
LAMA5) to achieve doxycycline (Dox)-induced knock-
down of a-5 laminin production (Figure 2A; Figures S2A–
S2D; Lian et al., 2013). Dox treatment of ishLAMA5 cell
lines resulted in a 60% reduction in a-5 laminin expression
(Figure 2A), and the karyotype of the 19-9-11 ishLAMA5
cell line was found to be normal (Figure S2E). Pluripotency
characteristics were maintained during LAMA5 knock-
down, as indicated by no significant change in the expres-
sion of the pluripotency marker Nanog (Figure 2B; Figures
S2F and S2G).
In a separate approach, CRISPR-Cas9 gene editing was
used in both H9 and 19-9-11 cell lines to create genetic196 Stem Cell Reports j Vol. 5 j 195–206 j August 11, 2015 j ª2015 The Autmutations that resulted in loss of function of the LAMA5
gene (Ran et al., 2013b). A set of guide RNAs (gRNA) target-
ing LAMA5 (Figure 2C; Table S2) was transfected into the
hPSCs concurrently with a Cas9-2A-GFP plasmid that en-
codes both Cas9 and GFP. Single GFP-positive cells were
expanded into colonies, and the gRNA target sites ampli-
fied from the genomic DNA of each colony were Sanger-
sequenced to confirm LAMA5 gene disruption (Figure 2C).
From this screening process, we identified an H9 line con-
taining a heterozygous mutation (Figures S3A and S3B)
and a 19-9-11 line containing a homozygous deletion/
frameshift mutation (Figure 2C). All mutated lines main-
tained expression of the pluripotency marker Nanog while
exhibiting significantly reduced expression of a-5 laminin
(Figures 2D and 2E; Figures S3C–S3E). The homozygous
19-9-11 knockout cell line was found to exhibit a normal
human karyotype (Figure S3F).
Disrupted a-5 Laminin Production Increases
Apoptosis, Causing Impaired Self-Renewal
Under defined culture conditions on the Synthemax
substrate, treatment of ishLAMA5 hPSC lines with
Dox resulted in an immediately apparent reduction in
cell number relative to both untreated and ishRNA
sequence-scrambled controls (Figure 3A; Figure S4A).
Several other factors related to cell self-renewal were
then examined to identify the cause of this disparity in
cell number. Production of Ki-67, a marker present during
active progression through the cell cycle (Gerdes et al.,
1984), was not significantly altered by a-5 laminin knock-
down in either H9 (Figure S4B) or 19-9-11 (Figure 3B)
cells. Cell-cycle distribution in a-5 laminin knockdown
and untreated cells was also quantified and found not
to be significantly affected by the disruption in a-5hors
Figure 2. Generation of hPSC Knockdown and Knockout Lines
(A) Doxycycline treatment of the Dox-inducible LAMA5 19-9-11 shRNA cell line resulted in decreased LAMA5 expression relative to
untreated ishLAMA5 cells, as measured by qRT-PCR after 3 days of culture on Synthemax (n = 3 independent samples/condition).
(B) Expression of the pluripotency marker Nanog was detected via flow cytometry and found to be maintained in ishLAMA5 19-9-11 cells
and scrambled shRNA controls cultured on Synthemax for 5 days (n = 3 independent samples/condition).
(C) Schematic of the human LAMA5 locus showing gRNA targeting locations for Cas9-mediated gene disruption. Sanger sequencing results
for the 19-9-11 KO line are shown below, with the red section indicating a homozygous deletion of the LAMA5 DNA sequence.
(D) Detection of LAMA5 in normal and homozygous knockout 19-9-11 iPSCs via RT-PCR using a primer within the deleted region of the
knockout line. Lack of amplification in the KO line verifies homozygous deletion of the gene as detected by Sanger sequencing.
(E) Nanog expression by normal and KO 19-9-11 iPSCs as measured by flow cytometry after 5 days of culture on Synthemax (n = 3
independent samples/condition).
*p < 0.01. Data are presented as mean ± SD. See also Figures S2 and S3.laminin production (Figures S4C and S4D). H9 and 19-9-
11 cells subjected to Cas9-mediated knockout of a-5
laminin function behaved similarly as the shRNA knock-
down cell lines, exhibiting dramatically reduced cellStem Cnumbers relative to control hPSCs cultured on Synthe-
max (Figure 3C; Figure S4E).
Apoptosis in H9 and 19-9-11 cultures with disrupted a-5
laminin production was evaluated to further investigateell Reports j Vol. 5 j 195–206 j August 11, 2015 j ª2015 The Authors 197
Figure 3. Disruption of a-5 Laminin Production Impacts 19-9-11 Cell Number and Apoptosis
(A) Dox treatment of ishLAMA5 19-9-11 cells cultured on Synthemax for 5 days resulted in decreased cell density compared with untreated
or scrambled ishRNA controls. Cells were initially seeded at 6,600 cells/cm2.
(B) Expression of the proliferation marker Ki67 as measured via flow cytometry after 5 days of culture on Synthemax.
(C) Cas9-mediated knockout of LAMA5 in 19-9-11 cells also resulted in decreased cell density.
(D) Dox treatment significantly increased apoptosis in 19-9-11 ishLAMA5 cells cultured for 5 days on Synthemax, as indicated by mea-
surement of caspase-3 via flow cytometry.
(E) Cas9-mediated knockout of LAMA5 in 19-9-11 cells increased apoptosis relative to wild-type (normal) 19-9-11 iPSCs cultured on
Synthemax for 5 days.
*p < 0.001 versus untreated cells, p^ < 0.001 versus Dox-treated scrambled control cells, #p < 0.001 versus wild-type 19-9-11 iPSCs (n = 3
independent samples/condition). Data are presented as mean ± SD. See also Figures S4 and S5.the cause of the observed decline in cell number in a-5
laminin knockdown and knockout hPSC lines. Increased
production of both cleaved caspase-3 (Li et al., 2014) and
annexin V (van Engeland et al., 1998; Zhang et al., 1997)
was found in both H9 and 19-9-11 inducible knockdown
cell lines relative to scrambled controls (Figure 3D; Fig-
ure S4F). H9 and 19-9-11 a-5 laminin knockout cell lines
also exhibited significantly increased expression of cleaved
caspase-3 and annexin V relative to unmodified hPSCs
(Figure 3E; Figures S5A and S5B).
Rescue of hPSC Self-Renewal via Culture on
Laminin-521
hPSCs possessing the Cas9-mediated disruption to LAMA5
were cultured on exogenously supplied laminin-521 to
determine whether the noted decrease in cell number
and increase in apoptosis could be reversed by the presen-
tation of a-5 laminin to the cells. Indeed, culture of
knockout H9 and 19-9-11 cells on exogenous laminin-
521 restored cell expansion to levels near those found198 Stem Cell Reports j Vol. 5 j 195–206 j August 11, 2015 j ª2015 The Autin normal hPSC controls (Figures 4A and 4B; Figures
S5C–S5E). The extent of rescue was dependent on the
laminin-521 coating density (Figure S5F). Although the
expansion of normal hPSCs was improved by culture on
exogenous vitronectin relative to Synthemax, use of vitro-
nectin as a culture substrate was unable to fully rescue the
expansion deficit resulting from LAMA5 knockout. This
finding indicates that rescue of the knockout cells was
likely specific to a-5 laminin and not simply due to the
presence of an exogenous ECM component that supports
undifferentiated hPSC culture. Laminin-111 was not used
as a comparison condition because pure human laminin-
111 does not support the attachment of normal hPSCs
(Figure S6A).
Culture on exogenously supplied laminin-521 was also
able to inhibit apoptosis in LAMA5 knockout H9 (Figures
S6A and S6B) and 19-9-11 (Figures 4C and 4D) cells. Specif-
ically, culture of knockout cells on laminin-521 resulted in
a full reduction of the apoptosis markers cleaved caspase-3
and annexin V to levels observed in wild-type H9 andhors
Figure 4. Culture of 19-9-11 LAMA5 Knockout Cells on Laminin-521, but Not Vitronectin, Results in Rescue of Cell Number
(A) Bright-field images of wild-type and LAMA5 KO 19-9-11 iPSCs cultured on laminin-521 (Lam 521) or Synthemax (Synth) for 3 days,
illustrating differences in cell density.
(B) Culture of Cas9-mediated LAMA5 KO 19-9-11 iPSCs on laminin-521 rescued cell number, as indicated by analysis of mean cell density
after 5 days of culture on Synthemax, vitronectin, or laminin-521. Cells were initially seeded at 6,600 cells/cm2.
(C and D) Apoptosis of 19-9-11 LAMA5 KO cells was also restored to wild-type levels by culture on laminin-521, as indicated by mea-
surement of caspase-3 (C) and annexin V (D) via flow cytometry after 5 days of culture.
Scale bars, 100 mm. *p < 0.001 versus wild-type 19-9-11 iPSCs cultured on the same substrate, p^ < 0.001 versus knockout cells cultured on
laminin-521 (n = 3 independent samples/condition). Data are presented as mean ± SD. See also Figure S5.19-9-11 cells. Culture on vitronectin was not able to reduce
apoptosis markers in the knockout lines.
Apoptotic Response Arises from Cell Blebbing and Is
Partly Reversed by Contractile Inhibition
The results reported in Figures 3 and 4 suggest that
increased apoptosis is at least partly responsible for the de-
creases in cell expansion observed upon disruption of a-5
laminin production. Additionally, a significant increase in
cell blebbing was observed in knockout cells cultured on
Synthemax (Figures 5A and 5B; Figure S6B), indicating a
role for cytoskeletal contractility in regulating apoptosis
under these conditions. Cell survival was not improved
by the addition of soluble laminin-521 to suspension cul-
tures of LAMA5 knockout 19-9-11 hPSCs (Figure S6C), sug-
gesting that binding of a-5 laminin to cell surface receptors
alone is not sufficient for cell rescue but that the presenta-
tion of a-5 laminin on the substrate surface may be needed
to provide appropriate ECM contacts for regulating cyto-
skeletal tension. Therefore, we next investigated mecha-
nisms linking a-5 laminin to this apoptotic response
by applying to H9 and 19-9-11 knockout lines a panel of
small molecule inhibitors targeting a range of apoptotic
pathway components as well as elements of the cytoskel-Stem Ceton (Table S3), followed by evaluation of cell expansion
and apoptosis. In both the H9 and 19-9-11 cell lines with
the LAMA5 knockout, treatment with either a Rho kinase
(ROCK) inhibitor (Y27632) or the myosin inhibitor bleb-
bistatin was able to increase cell expansion, resulting in
partial rescue. These levels of expansion remained lower
than those observed in normal hPSCs cultured on Synthe-
max (Figure 5C; Figure S6D). This partial rescue of cell
expansion was accompanied by a decrease in the expres-
sion of apoptosis markers relative to the untreated
knockout population (Figure 5D; Figure S6E). These results
suggest that relieving cell tension can at least partly restore
hPSC expansion by inhibiting apoptosis in the absence of
a-5 laminin.DISCUSSION
In this study, we first identified laminin as a prevalent
signature component of the ECM produced endogenously
by undifferentiated H9 hESCs and 19-9-11 iPSCs cultured
on three different defined substrates and subsequently
examined the role of endogenously produced a-5 laminin
in regulating the self-renewal and pluripotency markerell Reports j Vol. 5 j 195–206 j August 11, 2015 j ª2015 The Authors 199
Figure 5. Partial Rescue of Cell Self-
Renewal by Treatment with Inhibitors
of Cell Contractility
(A) F-actin staining of normal and KO 19-9-
11 cultures after 48 hr on Synthemax. White
boxes indicate regions examined at a higher
magnification. Scale bars, 100 mm (top) and
10 mm (bottom).
(B) Percentage of observed blebbing cells
in normal and KO 19-9-11 cultures, calcu-
lated as the number of cells with observed
blebs over the total number of cells per
image field.
(C) Treatment with inhibitors of cell
contractility (blebbistatin [Bleb] and
Y27632 [Y27]) was able to partially rescue
cell number for LAMA5 KO 19-9-11 iPSCs
cultured on Synthemax for 5 days. Cells were
initially seeded at 6,600 cells/cm2.
(D) Treatment with blebbistatin or Y27632
was also able to decrease apoptosis relative
to untreated LAMA5 KO 19-9-11 iPSCs, as
measured by flow cytometric analysis of
cleaved caspase-3 after 5 days of culture on
Synthemax.
*p < 0.001 versus wild-type 19-9-11 iPSCs,
p^ < 0.001 versus LAMA5 knockout iPSCs. n =
3 independent samples/condition. Data are
presented as mean ± SD. See also Figure S6.expression of these stem cells. We targeted the a-5 chain
specifically because the majority of integrin binding activ-
ity in the laminin molecule is thought to be conferred by
the C-terminal globular domains encoded on the a strand
(Beck et al., 1990; Deutzmann et al., 1990; Ido et al.,
2006; Li et al., 2002; Miner and Yurchenco, 2004). Further-
more, hPSCs predominantly express the a6b1 integrin,
which interacts strongly with these laminin globular do-
mains (Evseenko et al., 2009; Li et al., 2002; Meng et al.,
2010; Miyazaki et al., 2012; Rodin et al., 2010). Using two
different techniques to disrupt a-5 laminin production in
both hESC and iPSC lines, we found that hPSC expression
of the pluripotency marker Nanog was not strongly depen-
dent on a-5 laminin production but that hPSC self-renewal
diminished as a result of apoptosis in the absence of this
specific ECM component. Importantly, this apoptosis
could be reduced by supplying the knockout cells with an
exogenous source of a-5 laminin, such as culturing them
on a laminin-521 substrate (Rodin et al., 2014b).
To link this apoptotic response to an ECM-dependent
mechanism, we tested heterozygous and knockout
LAMA5 lines against several small-molecule inhibitors
and identified blebbistatin and the ROCK inhibitor
Y27632 as being able to reduce the apoptotic response of
the knockout lines cultured under defined conditions.200 Stem Cell Reports j Vol. 5 j 195–206 j August 11, 2015 j ª2015 The AutBlebbistatin and Y27632 are known to act in pluripotent
stem cells by preventing membrane blebbing, a phenome-
non that was observed during culture of a-5 laminin
knockout cells under defined conditions. These agents pre-
vent blebbing via inhibition of contractility (Chen et al.,
2010, 2014; Ohgushi et al., 2010; Ohgushi and Sasai,
2011; Watanabe et al., 2007), which may reduce anoikis,
a type of apoptotic cell death that occurs because of a
lack of cell-cell and cell-ECM contacts (Chen et al., 2010;
Kova´cs et al., 2004; Ohgushi et al., 2010; Ohgushi and
Sasai, 2011; Watanabe et al., 2007). Although contractility
inhibition did reduce apoptosis in a-5 laminin-deficient
cells, the restoration of hPSC self-renewal was only
partial, which does suggest the involvement of additional
signaling mechanisms in the hPSC response to a-5
laminin.
The specificity of the hPSC apoptotic response to a lack
of proper ECM contacts highlights the importance of sub-
strate interactions in regulating hPSC survival. Work by
our own group suggests that differentiating pluripotent
stem cells produce an ECM that is synergistic with the dif-
ferentiation cues given to the cells (Laperle et al., 2015).
Meanwhile, recent work by Meng et al. (2012) suggests
that matrices, media, and the soluble growth factors to
which hPSCs are exposed during culture have a synergistichors
Figure 6. Proposed Autocrine and Paracrine Positive Feedback
Loops in a-5 Laminin Self-Renewal Signaling
Undifferentiated hPSCs attach to a surface and receive soluble self-
renewal cues such as TGF-b. As part of the cellular response to these
maintenance cues, the hPSCs begin to produce an ECM enriched in
a-5 laminin. Signaling from this ECM microenvironment, in turn,
synergizes with the existing soluble cues and enables efficient self-
renewal of cells in contact with the endogenous ECM.effect on the growth and attachment of hPSCs under
defined culture conditions. For instance, in mouse mesan-
gial and early endoderm progenitor cells, transforming
growth factor b (TGF-b) signaling has been shown to drive
laminin production and increase the production of other
ECM components (Jiang et al., 2005; Sugiyama et al.,
2013; Tonary and Carnegie, 1996; Wells and Discher,
2008). It is possible that the a-5 laminin self-renewal
signal, combined with other soluble components, drives
hPSCs to produce a matrix that synergizes with these
self-renewal signals. The hPSCs subsequently produce a
matrix rich in a-5 laminin and receive supportive self-
renewal signals from that matrix in an autocrine and para-
crine signaling loop (Figure 6). Although this endogenous
ECM may be necessary for efficient self-renewal, it is
unlikely to be sufficient to fully support this process on
its own.
In this work, we developed multiple tools to interrogate
this autocrine and paracrine signaling loop involving a-5
laminin production by hPSCs. The use of the inducible
short hairpin lines allowed us to control the dynamics of
a-5 laminin production in a reversible manner. However,
the interpretation of results is complicated by the action
of the inducer, doxycycline, itself on cells; it is known to
inhibit matrix remodeling proteinases (Gajbhiye et al.,Stem C2014; Nip et al., 1993). In addition, knockdown was partial
and variable among hairpins from cell line to cell line, with
our best hairpin providing only 60% knockdown effi-
ciency. The Cas9-mediated knockout lines were developed
to address these drawbacks with the hairpin system and
provide a complete removal of the globular domains of
a-5 laminin in hPSCs. The Cas9 system can easily be
used, by simple modification of the guide RNA, to remove
other domains of a-5 laminin and, in general, provides un-
precedented precision in disrupting molecular signaling
domains in large, complex proteins like ECM components.
Application of the Cas9 tool in hPSCs offers a powerful way
to study stem cell signaling, particularly in multicellular
autocrine and paracrine contexts that involve reprogram-
ming and differentiation.
Together, the findings reported here have implications
with respect to not only understanding how existing sub-
strates maintain hPSC self-renewal but also for designing
new, defined substrates for hPSC culture. a-5 laminin is
known to be present in numerous widely used but unde-
fined hPSC culture systems. For instance, the function-
ality of MEF feeder cells in maintaining hPSCs is based
on MEF production of laminin 511 (Hongisto et al.,
2012). Additionally, a-5 laminin has been detected in Ma-
trigel, perhaps the most widely used substrate for hPSC
propagation (Hughes et al., 2010). Based on the results re-
ported in this work, we put forth the hypothesis that the
ability of many fully defined substrates to support hPSC
self-renewal (Amit et al., 2011; Azarin and Palecek, 2010;
Braam et al., 2008; Celiz et al., 2014; Chen et al., 2011;
Evseenko et al., 2009; Klim et al., 2010; Mei et al., 2010;
Melkoumian et al., 2010; Miyazaki et al., 2012; Rodin
et al., 2010, 2014b; Saha et al., 2011; Villa-Diaz et al.,
2010, 2013; Weber et al., 2010; Zweigerdt et al., 2011) is
likely due, in part, to their support of a-5 laminin deposi-
tion by the cultured cells. An illustrative example of such
a substrate is a peptide coating based on repeats of a hep-
arin binding motif that is designed to promote stem cell
attachment via binding of extracellular glycosamino-
glycan (GAG) domains on the stem cell surface (Klim
et al., 2010). However, because of the high-affinity interac-
tions that occur between heparin and the globular do-
mains of a-5 laminin (Hozumi et al., 2009; Katagiri
et al., 2014), it is also likely that these GAG-binding do-
mains are able to bind secreted ECM proteins, specifically
laminins. In another example, polymer substrate
screening studies have identified specific chemical func-
tionalities, namely carboxylic acid and ester residues, as
critical polymer features for the support of hPSC growth
(Mei et al., 2010; Saha et al., 2011). These same residues,
along with substrate surface potential, are thought to con-
trol the adsorption and conformation of laminin mole-
cules on a surface (Lin et al., 2014; Rodrı´guez Herna´ndezell Reports j Vol. 5 j 195–206 j August 11, 2015 j ª2015 The Authors 201
et al., 2007), suggesting that the ability of these materials
to support hPSC culture may be at least partly related to
laminin deposition. Synthetic polymer substrates such as
poly[2-(methacryloyloxy)ethyl dimethyl-(3-sulfopropyl)
ammonium hydroxide] (PMEDSAH) (Qian et al., 2014;
Villa-Diaz et al., 2010) may also support hPSC expansion
via a similar mechanism because we have observed the
production of a-5 laminin by hESCs cultured on this sub-
strate (Figure S6F).
We conclude that a-5 laminin endogenously produced
by hPSCs is a critical component of the undifferentiated
pluripotent stem cell ECM and that it is necessary for the
survival and expansion of these cells. This work describes
an autocrine and paracrine mechanism of self-renewal
signaling through the endogenous ECM of hPSCs and is
important in understanding the signals regulating self-
renewal and hPSC/substrate interactions. Our findings
have implications for the design and optimization of
hPSC culture substrates and scaffolds, whose performance
in supporting undifferentiated hPSCs may be related to
the ability of the environment to support the deposition
and production of a-5 laminin.EXPERIMENTAL PROCEDURES
hPSC Culture
H9 hESCs, 19-9-11 iPSCs, and all genetically modified lines
derived from these parental lines (WiCell) were maintained in
E8 medium on tissue culture polystyrene (TCPS) plates (BD Fal-
con, Corning) coated with Matrigel (WiCell) as described previ-
ously (Chen et al., 2011). Briefly, hESCs were cultured in 6-well
plates (BD Falcon) coated with Matrigel (83 mg/well) in 2.5 ml of
E8 medium/well. Cells were split at a ratio of 1:12 every 5 days
with Versene solution (Life Technologies). For matrix production
studies, cells were singularized with Accutase (Innovative Cell
Technologies) and seeded in E8 medium, with 5 mM Y27632
(Stemgent) present for the first 24 hr. In subsequent experiments
involving genetically modified cell lines, cells were singularized
with Accutase and seeded using mTeSR1 medium (WiCell), with
5 mM Y27632 present for the first 24 hr. H1 and CHB10 hESCs
were cultured on PMEDSAH as described by Villa-Diaz et al.
(2010).
ECM Coating Preparation
Six- and 12-well TCPS plates were coated with a range of defined
substrates according to the manufacturer’s recommendations.
Vitronectin (provided by the lab of Dr. Jamie Thomson, University
of Wisconsin-Madison) or laminin-521 (BioLamina) were diluted
in PBS and coated onto TCPS plates at a density of 0.61 mg/cm2
overnight at 37C. Synthemax (Corning) was coated onto TCPS
at a density of 3.3 mg/cm2 in PBS and incubated overnight at
37C. StemAdhere coatings were achieved by diluting 240 ml Ste-
mAdhere (STEMCELL Technologies) in 6 ml of StemAdhere dilu-
tion buffer, with 1 ml of this solution (1.02 mg/cm2) placed into
each well of a 6-well non-tissue culture polystyrene plate (BD202 Stem Cell Reports j Vol. 5 j 195–206 j August 11, 2015 j ª2015 The AutFalcon) and incubated overnight at 37C. Prior to cell seeding, all
plates were washed with sterile PBS to remove any non-adsorbed
coating.
Generation and Validation of Inducible shRNA hPSC
Lines
An inducible knockdown vector targeting the a-5 chain of lami-
nin (LAMA5) was constructed by combining a small interfering
RNA (siRNA) sequence (LAMA5, catalog no. s8066, Life Technolo-
gies) with an existing Tet-pLKO-puro backbone (Addgene,
plasmid 21915). These vectors were co-transfected with the helper
plasmids psPAX2 and pMD2.G (Addgene, plasmids 12260 and
12259) into HEK293TN cells (System Biosciences) for lentivirus
particle production. Virus-containing media were collected 48,
72, 96, and 120 hr after transfection. The supernatant was first
concentrated using Lenti-XTM Concentrator (Clontech Labora-
tories) according to the manufacturer’s instructions for storage
at 80C, and then used for hPSC infection in the presence of
6 mg/ml polybrene (Sigma). Lentiviral transduction was performed
on hPSCs by plating 100,000 cells/well in a 6-well plate with 2 ml
mTeSR and incubating with 25 ml viral supernatant overnight.
Transduced cells were cultured in mTeSR1 medium on Matrigel
for at least 3 days and then selected and clonally isolated in
mTeSR1 based on resistance to 1 mg/ml puromycin (Lian et al.,
2013).
Screening for knockdown efficiency was conducted via RT-PCR
and qRT-PCR against the human LAMA5 gene. For RT-PCR, total
RNA was extracted using DNA/RNA Shield with Quick-RNA
MiniPrep (Zymo Research) according to the manufacturer’s in-
structions. cDNA was generated from 1 mg of RNA using Omni-
script reverse transcriptase (QIAGEN) and Oligo-dT(20) primers
(Life Technologies). RT-PCR was performed using GoTaq Green
Master Mix (Promega) using primers (Table S4) from Integrated
DNA Technologies, and 2% agarose gel electrophoresis was per-
formed to visualize the PCR products. GAPDH and b-actin
(ACTB) were used as endogenous controls. qRT-PCR for LAMA5
was performed as described in a subsequent section. This
approach was used to produce the H9 ishLAMA5 (WiCell
line WIP01e-H9ishLAMA5), H9 ishSCR (WiCell line WIP02e-
H9ishSCR), 19-9-11 ishLAMA5 (WiCell line WIP03i-
IPSishLAMA5), and 19-9-11 ishSCR (WiCell line WIP04i-
IPSishSCR) cell lines. The 19-9-11 ishLAMA5 cell line was
submitted to WiCell for karyotyping.
Generation and Validation of Cas9 Gene-Disrupted
Lines
Cas9-mediated knockout (KO) of LAMA5 in hESCs and iPSCs was
performed according to the protocol published by Ran et al.
(2013b). H9 and 19-9-11 cells were first singularized with Accutase
(Innovative Cell Technologies) and electroporated using a Bio-Rad
Gene Pulser XL with 2 mg of each guide RNA (Table S1), 2 mg Cas9
plasmid (Addgene, plasmid 44719), and 1 mg of GFP plasmid per
one million cells. Three million cells were used in each electropo-
ration. Electroporated cells were plated (100,000 cells/cm2) onto
Matrigel-coated plates in mTESR1 medium containing 5 mM
Y27632 (Stemgent) and cultured for 48 hr. After 48 hr, cells were
again singularized with Accutase and sorted for GFP expressionhors
via fluorescence-activated cell sorting (FACS) (BD FACSAria).
Sorted cells were again re-plated on Matrigel at a low density of
1000 cells/cm2 and allowed to expand for 7—10days inmTeSRme-
dium. Individual colonies were isolated using an AMG EVOS XL
core cloning scope and expanded on Matrigel (H9) or laminin-
521 (19-9-11) for another 7-14 days, after which genomic DNA
was isolated from each clonal sample for an assay of LAMA5
disruption.
To assay target gene disruption, 500 ng of genomic DNAwas iso-
lated from cells using theQIAGENDNeasy blood and tissue kit and
combined with genomic DNA primers (final concentration,
0.2 mM) from IDT (Table S5) and AccuPrime high-fidelity Taq poly-
merase (Life Technologies) at the recommended annealing temper-
atures for 35 cycles on an Eppendorf Mastercycler Nexus GSX1.
PCR products were purified using a QIAGEN QIAquick PCR purifi-
cation kit. Genomic sequencing was performed by mixing 500 ng
of purified genomic PCR product with 1 ml of the genomic primer
used to amplify that segment, and purified water was added to
bring the total volume to 25 ml. Sampleswere submitted to theUni-
versity of Wisconsin Biotechnology Center DNA Sequence Facility
for Sanger sequencing. Sequencing results were visualized using
Benchling software.
Heterozygous mutation of LAMA5 and gene disruption effi-
ciency were assessed using a T7 endonuclease I assay as described
previously (Cho et al., 2013; Ran et al., 2013a, 2013b; Yang et al.,
2013). Briefly, 1 mg of purified genomic DNA was hybridized in
NEB buffer II (New England Biolabs), followed by addition of 1 ml
of T7 endonuclease to each T7 digestion and incubation at 37C
for 15 min prior to addition of 2.1 ml stop solution. Purified
genomic DNA, hybridization product, and T7 digest product
were visualized on a 2% agarose gel and imaged using a Bio-Rad
Gel Doc XR+. This approach was used to generate the H9 Cas9
Het (WiCell line WIP07e-H9Cas9Het) and 19-9-11 Cas9 KO
(WiCell line WIP05i-IPSCas9KO) cell lines, and the latter was sub-
mitted for karyotype analysis (WiCell).Immunocytochemical Detection of ECM
The deposition of endogenous ECM proteins onto uncoated
and ECM-coated TCPS plates by H9 hESCs and 19-9-11 iPSCs
was assessed via immunocytochemical staining. Samples were
fixed in 10% formalin (Sigma) and permeabilized using 1%
Triton X-100 (Sigma) in PBS. Primary antibodies against human
fibronectin (Santa Cruz Biotechnology, catalog no. SC80559),
laminin (Abcam, catalog no. ab30320), a-5 laminin (Millipore,
catalog no. MAB1924), vitronectin (Santa Cruz Biotechnology,
catalog no. SC74485), collagen type IV (Santa Cruz Biotech-
nology, catalog no. SC52317), and collagen type 1 (Sigma, cata-
log no. C2456) were diluted 1:500 in 3% BSA in PBS and allowed
to incubate overnight at 4C, followed by rinsing in PBS and
incubation with Alexa Fluor 488- and 568-conjugated goat
anti-mouse or goat anti-rabbit secondary antibodies (Life Tech-
nologies, catalog nos. A10667 and A11031, respectively) in 3%
BSA at room temperature for 1 hr. Cell nuclei were counter-
stained with 1 mg/ml DAPI (40,6-diamidino-2-phenylindole
dihydrochloride, Life Technologies, catalog no. D1306), and
fluorescent images were captured using a Nikon IX51 epifluores-
cence microscope.Stem CApoptosis, Cell Cycle, and Pluripotency Analysis via
Flow Cytometry
hPSCs cultured on the aforementioned coatings were singularized
with Accutase and fixed in cold 90% methanol. Primary anti-
bodies against annexin V (1:500, Santa Cruz Biotechnology,
catalog no. SC74458), Nanog (1:500, Cell Signaling Technology,
catalog no. 4893), cleaved caspase-3 (1:250, Cell Signaling Tech-
nology, catalog no. 9664), Ki67 (1:500, Abcam, 15580), and an
isotype control (1:500 and 1:250, mouse immunoglobulin G1
[IgG1], BD Biosciences, catalog no. 550878) were prepared in
0.3% BSA in PBS and incubated with samples overnight at 4C. Af-
ter washing, samples were incubated for 1 hr at room temperature
with Alexa Fluor 488- or 568-conjugated goat anti-mouse or goat
anti-rabbit secondary antibodies (Life Technologies, catalog nos.
A10667 and A11031, respectively) diluted 1:500 in 0.3% BSA.
Samples were analyzed on a BDCanto flow cytometer using BD
FACSdiva software, and negative control gating was performed
on samples treated with an isotype control primary antibody
and a secondary antibody identical to that used for samples. For
cell-cycle analysis, samples were stained with propidium iodide
(Life Technologies), and cell-cycle distribution was determined us-
ing theModFit LT version 4 software package from Verity Software
House.
qRT-PCR
mRNA was isolated from cultured cells using the QIAGEN RNeasy
Plus mini kit. cDNA was produced using the Applied Biosystems
high-capacity cDNA reverse transcription kit. Gene expression
was assessed via qRT-PCR using the NANOG, and LAMA5 human
TaqMan gene expression assays from Applied Biosystems. Samples
weremeasured using a StepOne real-time PCR system (Applied Bio-
systems), and data analysis was performed using the DDCtmethod
relative to GAPDH.
Statistical Analysis
Statistical analysis was performed via one-way ANOVA with a
Tukey honest significant difference (HSD) post hoc test using
the KaleidaGraph software package. p Values less than or equal
to 0.05 were considered statistically significant. Data are pre-
sented as mean ± SD. All experiments were repeated a minimum
of two times with three independent samples per condition each
time.
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